Recombinant Escherichia coli O157:H7 Phosphoserine aminotransferase (serC)

What is Phosphoserine aminotransferase (serC) and what is its role in E. coli O157:H7?

Phosphoserine aminotransferase (serC) is an enzyme (EC 2.6.1.52) that catalyzes a key step in the serine biosynthesis pathway. In E. coli O157:H7, serC (also known as Phosphohydroxythreonine aminotransferase) is a 362-amino acid protein that plays an essential role in amino acid metabolism . While E. coli O157:H7 is a major food-borne pathogen that causes hemorrhagic colitis and hemolytic uremic syndrome, serC is part of its core metabolic machinery rather than a direct virulence factor . The enzyme functions in primary metabolism, catalyzing the reversible conversion of 3-phosphohydroxypyruvate to L-phosphoserine using pyridoxal 5'-phosphate as a cofactor.

What expression systems are recommended for producing recombinant serC from E. coli O157:H7?

For efficient expression of recombinant E. coli O157:H7 serC, E. coli-based expression systems are most commonly used due to their compatibility with the target protein . The following expression strategy is recommended:

• Vector selection: pET expression vectors (such as pET21d or pET22b) have been successfully used for similar E. coli proteins . These vectors provide strong T7 promoter-driven expression and options for different fusion tags.

• Host strain: BL21(DE3) derivatives are recommended as they lack certain proteases and contain the T7 RNA polymerase gene required for pET vector expression.

• Expression conditions:

  • Induction with 0.5-1.0 mM IPTG at OD600 of 0.6-0.8

  • Post-induction expression at 18-25°C for 16-18 hours (reduced temperature to enhance protein solubility)

  • Supplementation with pyridoxal 5'-phosphate (50-100 μM) in the growth medium may improve proper folding

• Fusion tags: C-terminal 6xHis-tag is preferable for minimal interference with enzyme activity, though MBP fusions (using vectors like pMalc2) have been successfully used for similar proteins from E. coli O157:H7 .

What is the most effective purification protocol for obtaining highly pure serC protein for crystallization studies?

A multi-step purification protocol is recommended for obtaining crystallization-grade serC protein:

Step 1: Initial Capture

• Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for His-tagged serC

• Buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 20 mM imidazole (binding)

• Elution with 250 mM imidazole gradient

• Expected purity: >85% as determined by SDS-PAGE

Step 2: Intermediate Purification

• Ion exchange chromatography (IEX) using Q-Sepharose

• Buffer: 20 mM Tris-HCl pH 8.0, 50 mM NaCl

• Elution with 50-500 mM NaCl gradient

• Expected purity: >90%

Step 3: Polishing

• Size exclusion chromatography using Superdex 200

• Buffer: 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.1 mM pyridoxal 5'-phosphate

• Expected final purity: >98%

Step 4: Concentration

• Concentrate to 10-15 mg/mL using 10 kDa MWCO centrifugal filters

• Storage in 20 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT, 0.1 mM pyridoxal 5'-phosphate, 5% glycerol

• Flash freeze aliquots in liquid nitrogen and store at -80°C

The protein's stability can be assessed through differential scanning fluorimetry (DSF) with various buffer conditions to optimize crystallization conditions.

How can the enzymatic activity of recombinant serC be reliably measured?

The catalytic activity of serC can be measured using the following spectrophotometric assay:

Forward Reaction (Phosphoserine formation)

• Reaction mixture (1 mL):

  • 50 mM HEPES buffer (pH 7.5)

  • 5 mM 3-phosphohydroxypyruvate

  • 10 mM L-glutamate

  • 0.1 mM pyridoxal 5'-phosphate

  • 1-5 μg purified serC enzyme

• Monitor the decrease in absorbance at 340 nm due to the oxidation of NADH in a coupled assay system:

  • Add 0.2 mM NADH and 2 units of L-glutamate dehydrogenase

  • Calculate activity using Δε340 = 6,220 M^-1 cm^-1

Reverse Reaction (3-phosphohydroxypyruvate formation)

• Reaction mixture (1 mL):

  • 50 mM HEPES buffer (pH 7.5)

  • 5 mM L-phosphoserine

  • 5 mM α-ketoglutarate

  • 0.1 mM pyridoxal 5'-phosphate

  • 1-5 μg purified serC enzyme

• Monitor the formation of 3-phosphohydroxypyruvate by coupling to NADH oxidation:

  • Add 0.2 mM NADH and 2 units of L-lactate dehydrogenase

  • Calculate activity using Δε340 = 6,220 M^-1 cm^-1

Kinetic parameters (Km, Vmax, kcat) should be determined under optimal conditions (pH 7.5, 30°C). For accurate measurement, ensure that the recombinant serC has been properly reconstituted in the appropriate buffer .

What methods are available for studying the protein-protein interactions of serC in E. coli O157:H7?

Several complementary approaches can be employed to study serC protein interactions:

In vitro methods:

• Pull-down assays: Using His-tagged serC as bait to identify interaction partners from E. coli O157:H7 lysates, followed by mass spectrometry identification.

• Surface Plasmon Resonance (SPR): For quantitative analysis of binding kinetics between serC and potential partners, with purified serC immobilized on a sensor chip.

• Isothermal Titration Calorimetry (ITC): To determine binding thermodynamics and stoichiometry of interactions.

In vivo methods:

• Bacterial two-hybrid system: Adapting systems like BACTH (Bacterial Adenylate Cyclase Two-Hybrid) for studying serC interactions within the bacterial context.

• Co-immunoprecipitation: Using anti-serC antibodies (which can be developed using recombinant serC as immunogen, similar to the approach used for EspA and intimin antibodies) .

• Crosslinking coupled with mass spectrometry: To capture transient interactions in the native cellular environment.

Structural characterization:
X-ray crystallography or cryo-EM of serC complexes with interaction partners to determine atomic-level details of binding interfaces.

When investigating serC interactions, particularly important to explore are associations with other enzymes in the serine biosynthesis pathway and potential interactions with metabolic regulators that might influence pathogenicity in E. coli O157:H7.

How does serC contribute to the metabolic adaptation of E. coli O157:H7 in different host environments?

SerC plays a crucial role in E. coli O157:H7's metabolic adaptation across different host environments:

In bovine intestine (primary reservoir):
E. coli O157:H7 colonizes the bovine terminal rectum as its principal site . In this environment, serC's role in serine biosynthesis likely supports bacterial growth under conditions where exogenous serine may be limited. Metabolic adaptations are essential for the bacterium to compete with commensal microbiota and establish colonization.

During human infection:
When E. coli O157:H7 infects humans, it must adapt to different nutritional conditions and host defense mechanisms. The metabolic flexibility conferred by enzymes like serC may contribute to the bacterium's ability to colonize and cause disease. While not a direct virulence factor, serC supports basic metabolism that underpins pathogenicity.

Adaptation table comparing metabolic requirements:

While serC itself may not directly interact with virulence factors, its metabolic role provides the foundation for the expression of over 131 proteins with virulence-related functions identified in the E. coli O157:H7 genome . The metabolic network involving serC likely interfaces with pathogenicity islands and horizontally acquired genes that distinguish this pathogenic strain from commensal E. coli.

Is there evidence that serC is differentially expressed during various stages of E. coli O157:H7 infection?

While the provided search results don't specifically address serC expression patterns, we can derive insights from expression patterns of other E. coli O157:H7 proteins during infection:

Expression pattern analysis:
Based on the temporal expression pattern observed with H7 flagella, which shows early expression followed by suppression during later stages of microcolony formation and attaching/effacing lesion development , we can hypothesize potential regulation patterns for metabolic genes like serC:

• Initial colonization phase: Likely high serC expression to support rapid growth and establishment in a new environment.

• Attachment phase: Expression potentially coordinated with adhesins like H7 flagella, which act as important adhesins to bovine intestinal epithelium .

• Microcolony formation: Possible modulation of serC expression to adapt to changing nutrient availability within bacterial communities.

• Late infection stage: Expression likely readjusts to support production of toxins and virulence factors.

To investigate serC expression patterns experimentally, researchers should consider:

• qRT-PCR analysis of serC expression during different infection stages

• Promoter-reporter fusion studies (e.g., serC promoter-GFP)

• Proteomics approaches to measure SerC protein levels in different infection conditions

• RNA-seq analysis comparing transcriptomes across infection timelines

These approaches would reveal whether serC is differentially regulated during the infection process and might identify potential regulatory factors controlling its expression.

How does serC function compare between pathogenic E. coli O157:H7 and non-pathogenic E. coli strains?

Comparative analysis of serC between pathogenic E. coli O157:H7 and non-pathogenic strains like K-12 reveals important insights:

Functional comparison:
The basic catalytic function of serC is likely conserved across E. coli strains, but several factors may influence its role in pathogenic vs. non-pathogenic contexts:

Strain-specific adaptations:
E. coli O157:H7 has acquired specific tRNAs that are involved in the efficient expression of strain-specific genes . This codon usage adaptation may extend to the expression of metabolic genes like serC, potentially optimizing its translation efficiency in the pathogenic strain.

To experimentally assess these differences, complementation studies could be performed where the serC gene from E. coli O157:H7 is expressed in a K-12 serC mutant, and vice versa, followed by comparative analysis of growth, metabolic profiles, and stress responses.

How can researchers use recombinant serC for developing novel diagnostic tools for E. coli O157:H7?

Recombinant serC can be leveraged for developing innovative diagnostic approaches for E. coli O157:H7 detection:

Antibody-based detection systems:

• Generate specific antibodies against E. coli O157:H7 serC using techniques similar to those used for EspA and intimin antibodies .

• Develop ELISA-based detection systems using anti-serC antibodies in combination with antibodies against known virulence factors (EspA, intimin).

• Create multiplexed lateral flow assays incorporating serC detection alongside O157 and H7 antigen detection.

Enzymatic activity-based detection:

• Design diagnostic assays based on serC's enzymatic activity, measuring phosphoserine production in samples.

• Develop colorimetric tests that couple serC activity to reporter enzymes producing visible color changes in positive samples.

Genetic detection approaches:

• Design PCR primers targeting strain-specific variations in the serC gene or its flanking regions.

• Incorporate serC detection into multiplex PCR panels alongside virulence genes for comprehensive strain typing.

Diagnostic performance metrics:

• Sensitivity: While serC alone may not provide sufficient specificity (as it's present in non-pathogenic strains), combining serC detection with virulence markers can enhance sensitivity.

• Specificity: By targeting any strain-specific variations in serC sequence or regulation, specificity for E. coli O157:H7 can be improved.

• Sample preparation: Less extensive than current protocols that require selective enrichment on media like SMAC agar supplemented with MUG, cefixime, potassium tellurite, and vancomycin .

Integrating serC detection with established diagnostic markers for E. coli O157:H7 could potentially increase diagnostic accuracy and reduce detection time in both clinical and food safety applications.

What are the best approaches for studying the three-dimensional structure of serC and its substrate binding sites?

To elucidate the 3D structure of E. coli O157:H7 serC and characterize its substrate binding sites, researchers should employ a multi-technique approach:

X-ray crystallography:

• Protein preparation:

  • Express and purify to >98% homogeneity using the protocol described in FAQ 2.1

  • Screen for optimal buffer conditions using thermal shift assays

  • Include pyridoxal 5'-phosphate cofactor during purification

• Crystallization screening:

  • Initial screening using commercial sparse matrix screens

  • Optimization of promising conditions by varying pH, precipitant concentration, and additives

  • Co-crystallization with substrates (3-phosphohydroxypyruvate, L-phosphoserine) and/or product analogs

• Data collection and structure determination:

  • High-resolution diffraction data collection at synchrotron radiation facilities

  • Molecular replacement using known serC structures as search models

  • Model building and refinement to achieve high-quality structure

Complementary approaches:

• Nuclear Magnetic Resonance (NMR) for solution structure and dynamics:

  • Isotope labeling with 15N and 13C

  • Analysis of protein-ligand interactions in solution

  • Investigation of conformational changes upon substrate binding

• Cryo-Electron Microscopy for structural studies in different functional states:

  • Sample preparation on grids with thin vitreous ice

  • Collection of high-resolution image data

  • 3D reconstruction and model building

• Computational methods:

  • Homology modeling based on related aminotransferase structures

  • Molecular dynamics simulations to study substrate binding and catalytic mechanism

  • Virtual screening to identify potential inhibitors

Structure-Function Analysis:
After obtaining the 3D structure, site-directed mutagenesis of key residues in the substrate binding pocket and catalytic site should be performed to validate their roles, followed by kinetic analysis of the mutant proteins.

What methods can be used to investigate the potential role of serC in antibiotic resistance mechanisms in E. coli O157:H7?

Investigating the relationship between serC and antibiotic resistance in E. coli O157:H7 requires a systematic approach:

Genetic manipulation approaches:

• Gene knockout/knockdown studies:

  • Create serC deletion mutants using CRISPR-Cas9 or lambda Red recombination

  • Develop inducible antisense RNA systems for controlled serC knockdown

  • Compare antibiotic susceptibility profiles of wild-type and mutant strains using standardized methods (broth microdilution, disk diffusion)

• Overexpression studies:

  • Express serC at various levels using inducible promoters

  • Assess changes in minimum inhibitory concentrations (MICs) for different antibiotic classes

  • Monitor growth rates and cell morphology under antibiotic stress conditions

Metabolomic approaches:

• Measure changes in amino acid pools (especially serine) in response to antibiotic exposure

• Compare metabolic profiles between wild-type and serC-modified strains under antibiotic pressure

• Identify metabolic adaptations potentially contributing to resistance

Transcriptomic/proteomic integration:

• Perform RNA-seq on wild-type and serC mutant strains with and without antibiotic exposure

• Use comparative proteomics to identify proteins differentially expressed in response to serC modulation

• Map changes onto known resistance pathways and metabolic networks

Experimental design for antibiotic testing:

These approaches would help determine whether serC plays a direct role in antibiotic resistance or if its influence is indirect through broader metabolic adaptations that support resistance mechanisms.

How has serC evolved across different pathogenic E. coli lineages compared to the O157:H7 strain?

The evolution of serC across E. coli pathotypes reveals insights into metabolic adaptation and pathogen evolution:

Evolutionary context:
E. coli O157:H7 is believed to have descended from the less virulent strain E. coli O55:H7 through a series of sequential evolutionary events, including acquisition of bacteriophages carrying Shiga toxin genes, acquisition of the pO157 plasmid and rfb region, and loss of the ability to ferment D-sorbitol and beta-glucuronidase activity . While these events shaped the virulence profile, the evolution of metabolic genes like serC may have followed a different trajectory.

Comparative analysis across pathotypes:

Evolutionary pressures:

• Purifying selection: The core enzymatic function of serC is likely under strong purifying selection to maintain its essential metabolic role.

• Host adaptation: Subtle variations in serC may reflect adaptation to different host environments.

• Integration with acquired elements: While serC itself is part of the core genome, its regulation may have evolved to integrate with horizontally acquired genetic elements that characterize different pathotypes .

Methodological approach for evolutionary analysis:

• Phylogenetic analysis of serC sequences across diverse E. coli strains

• Calculation of dN/dS ratios to detect selection signatures

• Ancestral sequence reconstruction to identify key mutations in the evolutionary history

• Experimental characterization of serC variants from different pathotypes

Understanding serC evolution provides context for its current function in E. coli O157:H7 and may reveal adaptations that contribute to the success of this pathogen in its ecological niche.

What computational tools and databases are most useful for analyzing serC sequence variations and predicting functional impacts?

Researchers studying serC sequence variations can utilize these specialized computational resources:

Sequence databases and repositories:

• UniProt/Swiss-Prot: Contains curated serC entries with functional annotations

• NCBI RefSeq: Comprehensive collection of serC sequences across bacterial species

• PATRIC: Specialized database for pathogenic bacteria with comparative genomics tools

• SEED: Metabolic reconstruction database with pathway context for serC

Sequence analysis tools:

• BLAST/HMMER: For identifying serC homologs across different organisms

• Clustal Omega/MUSCLE: Multiple sequence alignment tools to compare serC sequences

• Jalview: Visualization and analysis of sequence conservation patterns

• ConSurf: Mapping of conservation scores onto protein structures

Structural analysis tools:

• I-TASSER/AlphaFold2: For structure prediction of serC variants

• PyMOL/Chimera: Visualization of structural impacts of sequence variations

• FoldX/Rosetta: Energy calculations to predict stability changes from mutations

• SiteMap/CASTp: Prediction of binding site changes due to sequence variations

Functional impact prediction:

• SIFT/PolyPhen: Prediction of functional effects of amino acid substitutions

• PROVEAN: Predicts functional impacts of amino acid changes and indels

• EVmutation: Uses evolutionary couplings to predict mutation effects

• DynaMut: Predicts protein dynamics changes upon mutation

Integrated analysis workflow:

• Retrieve serC sequences from diverse E. coli strains

• Perform multiple sequence alignment

• Map conservation onto 3D structure

• Identify strain-specific variations

• Predict functional impacts

• Select candidate variations for experimental validation

When analyzing serC variations, it's important to consider not only effects on enzyme activity but also potential impacts on protein-protein interactions, regulatory binding sites, and expression levels. Integration of multiple computational approaches provides higher confidence predictions for experimental validation.

How can researchers design experiments to test the hypothesis that serC mutations might affect E. coli O157:H7 virulence?

Testing the relationship between serC mutations and E. coli O157:H7 virulence requires a comprehensive experimental design:

Phase 1: Identification of naturally occurring serC variants

• Sequence serC from diverse clinical and environmental O157:H7 isolates

• Identify non-synonymous mutations and correlate with isolation source/virulence phenotypes

• Select mutations for functional characterization based on:

  • Location in protein structure (catalytic site, substrate binding pocket, etc.)

  • Predicted functional impact using computational tools

  • Frequency in the population

Phase 2: In vitro characterization

• Site-directed mutagenesis:

  • Create a panel of serC variants in expression vectors

  • Express and purify recombinant proteins

  • Perform enzymatic assays to determine changes in kinetic parameters

• Chromosomal mutation introduction:

  • Introduce selected mutations into the O157:H7 chromosome using scarless genome editing techniques

  • Create a strain library with different serC variants

• Phenotypic characterization:

  • Growth curves under various conditions (minimal media, stress conditions)

  • Metabolomic profiling to detect changes in serine and related metabolites

  • Assessment of virulence factor expression (Shiga toxins, EspA, intimin)

Phase 3: Ex vivo and in vivo models

• Tissue culture models:

  • Adhesion assays to bovine rectal primary epithelial cells

  • Invasion assays using human intestinal epithelial cell lines

  • Transwell systems to assess polarized cell interactions

• Organ culture models:

  • Bovine rectal tissue explants to assess colonization efficiency

  • Human intestinal organoids to evaluate pathogenic potential

• Animal models:

  • Streptomycin-treated mouse model for colonization studies

  • Infant rabbit model for pathogenesis assessment

  • Monitoring of key parameters:

    • Colonization efficiency

    • Attaching and effacing lesion formation

    • Toxin production

    • Immune response elicitation

Experimental controls:

• Wild-type E. coli O157:H7

• serC deletion mutant complemented with wild-type serC

• Non-pathogenic E. coli K-12 expressing O157:H7 serC

This systematic approach would allow researchers to determine whether serC mutations affect virulence directly (through altered metabolism supporting virulence factor expression) or indirectly (through general fitness effects). The results would provide insights into the role of metabolic adaptations in pathogenicity.

How can recombinant serC be used to develop targeted antimicrobial strategies against E. coli O157:H7?

Recombinant serC offers several avenues for developing targeted antimicrobial strategies:

Enzyme inhibitor development:

• Structure-based drug design:

  • Use the 3D structure of serC to identify unique binding pockets

  • Virtual screening of compound libraries against these pockets

  • Rational design of inhibitors that selectively target E. coli O157:H7 serC

  • Optimization of lead compounds for specificity and potency

• High-throughput screening:

  • Develop enzymatic assays suitable for HTS format

  • Screen chemical libraries for inhibitors

  • Validate hits using secondary assays and counter-screens against human enzymes

Immunological approaches:

• Vaccine development:

  • Evaluate recombinant serC as a potential vaccine antigen

  • Test for immune response and protection in animal models

  • Combine with established virulence factors (EspA, intimin) for multivalent vaccines

• Antibody-based therapeutics:

  • Generate high-affinity antibodies against surface-exposed regions of serC

  • Develop antibody-drug conjugates for targeted delivery

  • Test efficacy in preventing colonization in animal models

Metabolic targeting:

• Pathway manipulation:

  • Design interventions that create metabolic dependence on serine uptake

  • Develop serine analogs that competitively inhibit serC function

  • Combine serC inhibition with serine pathway blockade for synergistic effects

Targeted delivery strategies:

• Bacteriophage-based delivery:

  • Engineer O157:H7-specific bacteriophages to deliver serC-targeting agents

  • Utilize the extensively studied bacteriophage inventory of O157:H7

  • Design phages that specifically target E. coli in the bovine reservoir to reduce transmission

Efficacy assessment metrics:

• Reduction in bacterial load in vitro and in vivo

• Prevention of attachment to epithelial cells

• Inhibition of virulence factor expression

• Minimal disruption to commensal microbiota

These approaches leverage the recombinant serC as both a target for antimicrobial development and a tool for validating intervention strategies, potentially leading to novel therapeutics for E. coli O157:H7 infections.

What approaches can be used to investigate serC regulation in response to environmental signals relevant to E. coli O157:H7 pathogenesis?

Understanding serC regulation in response to environmental cues requires multi-level analysis:

Transcriptional regulation analysis:

• Promoter characterization:

  • Identify the serC promoter region and potential regulatory elements

  • Develop reporter constructs (e.g., serC promoter-GFP fusions)

  • Test promoter activity under conditions mimicking different stages of infection

• Transcription factor binding:

  • Perform chromatin immunoprecipitation (ChIP) to identify proteins binding to the serC promoter

  • Electrophoretic mobility shift assays (EMSA) to confirm direct interactions

  • DNA footprinting to map precise binding sites

Environmental response profiling:
Test serC expression under conditions relevant to E. coli O157:H7 lifestyle:

Post-transcriptional regulation:

• Small RNA regulation:

  • Identify potential sRNA interactions with serC mRNA

  • Test effects of known sRNA regulators on serC expression

  • RNA-protein pulldown to identify RNA-binding proteins affecting serC

• Translational control:

  • Ribosome profiling to assess translation efficiency under different conditions

  • Analysis of the role of O157:H7-specific tRNAs in serC expression

Integration with virulence regulation:

• Compare serC regulation with known virulence factor expression patterns

• Test effects of virulence regulators (Ler, GrlA, etc.) on serC expression

• Determine if metabolic changes involving serC trigger virulence gene expression

Methodological considerations:

• Use both laboratory culture conditions and more authentic models (e.g., bovine rectal epithelial cells)

• Apply systems biology approaches to place serC regulation in the context of global metabolic and virulence networks

• Consider single-cell approaches to detect heterogeneity in expression within bacterial populations

These approaches would provide comprehensive understanding of how serC regulation is integrated with E. coli O157:H7 pathogenesis and environmental adaptation.

How can researchers design high-throughput screening assays to identify molecules that specifically target serC function in E. coli O157:H7?

Developing effective high-throughput screening (HTS) assays for serC-targeting molecules requires careful assay design and validation:

Primary enzymatic activity assays:

• Spectrophotometric coupled assay:

  • Couple serC reaction to NADH oxidation for continuous monitoring at 340 nm

  • Adapt to 384-well microplate format for high throughput

  • Optimize reagent concentrations for signal:noise ratio >10

  • Z' factor validation (aim for >0.7 for robust HTS)

• Fluorescence-based assay:

  • Develop fluorogenic substrate analogs for direct activity measurement

  • Monitor fluorescence changes upon substrate conversion

  • Miniaturize to 1536-well format for ultra-high throughput

Secondary validation assays:

• Orthogonal activity assays:

  • HPLC-based detection of reaction products

  • Mass spectrometry verification of mechanism

• Binding assays:

  • Thermal shift assays to detect stabilizing/destabilizing compounds

  • Surface plasmon resonance to measure direct binding kinetics

  • Isothermal titration calorimetry for binding thermodynamics

Counter-screens and selectivity assays:

• Mammalian enzyme counter-screens:

  • Test compounds against human serine biosynthesis enzymes

  • Establish selectivity index (IC50 human/IC50 bacterial)

• Broad spectrum assessment:

  • Test against serC from non-pathogenic E. coli strains

  • Evaluate activity against serC from other enteric bacteria

Cell-based assays:

• Growth inhibition:

  • Minimal media growth assays where serC function is essential

  • Rescue experiments with exogenous serine supplementation

• Target engagement:

  • Cellular thermal shift assay (CETSA) to confirm binding in intact cells

  • Metabolomics to measure target pathway inhibition

Assay development workflow:

Compound libraries for screening:

• Diverse small molecule collections (100,000-1,000,000 compounds)

• Focused libraries targeting other aminotransferases

• Natural product extracts

• Fragment libraries for fragment-based drug discovery

This comprehensive HTS strategy would enable identification of selective serC inhibitors that could serve as starting points for antimicrobial development against E. coli O157:H7.

What are the most promising research directions for studying serC in the context of E. coli O157:H7 pathogenesis?

The exploration of serC in E. coli O157:H7 pathogenesis offers several high-potential research avenues that could lead to significant advances in our understanding and control of this pathogen:

• Metabolic integration with virulence: Investigating how serC and serine metabolism interface with virulence factor expression could reveal new paradigms in pathogen regulation. Particular focus should be placed on temporal coordination with adhesins like H7 flagella and the transition between colonization and virulence phases.

• Host-pathogen metabolic interactions: Studying how serC-dependent metabolism adapts to different host environments, particularly the bovine reservoir where E. coli O157:H7 primarily colonizes the terminal rectum , could reveal adaptation mechanisms that support persistent colonization.

• Strain-specific metabolic adaptations: Comparative analysis of serC function across E. coli pathotypes could identify metabolic signatures specific to the O157:H7 serotype and reveal how core metabolism has evolved alongside horizontally acquired virulence elements .

• Antimicrobial targeting strategies: Developing serC-targeted intervention approaches, potentially in combination with strategies targeting strain-specific functions like the H7 flagellum , could lead to novel therapeutic or preventive measures against this pathogen.

• Systems biology integration: Placing serC within whole-cell metabolic models of E. coli O157:H7 would provide a framework for understanding how perturbations to serine metabolism affect global cellular physiology and virulence capabilities.

These research directions leverage our current understanding of both E. coli O157:H7 pathogenicity mechanisms and the essential role of serC in bacterial metabolism, creating opportunities for fundamental discoveries and translational advances.

What critical knowledge gaps remain regarding serC function in E. coli O157:H7?

Despite advances in understanding E. coli O157:H7 biology, several critical knowledge gaps regarding serC function remain to be addressed:

• Strain-specific enzymatic properties: Whether serC from E. coli O157:H7 exhibits different kinetic parameters, stability, or regulatory properties compared to non-pathogenic strains remains poorly characterized. These differences, if they exist, could impact metabolic fitness in host environments.

• Regulatory networks: The specific transcriptional, translational, and post-translational regulatory mechanisms controlling serC expression in response to environmental cues encountered during infection remain largely unknown. Understanding how these networks differ from non-pathogenic E. coli would provide insight into pathogen adaptation.

• Metabolic connectivity: The precise connections between serine metabolism and virulence factor expression in E. coli O157:H7 have not been systematically mapped. This includes potential roles in supporting type III secretion system function, which is critical for the delivery of effector proteins like Tir .

• Host environment adaptation: How serC activity is modulated to support colonization of different host niches, particularly the bovine terminal rectum , remains poorly understood. This includes adaptation to host defense mechanisms and nutrient availability changes.

• Protein interaction network: The protein-protein interactions involving serC in E. coli O157:H7 have not been comprehensively characterized. These interactions could reveal unexpected roles beyond its canonical enzymatic function.

• Contribution to stress resistance: The potential role of serC and serine metabolism in supporting E. coli O157:H7 resistance to environmental stresses, host defenses, and antibiotic exposure remains to be fully elucidated.

Addressing these knowledge gaps would significantly advance our understanding of how core metabolic enzymes like serC contribute to the pathogenic lifestyle of E. coli O157:H7 and potentially reveal new approaches for pathogen control.

How might research on serC contribute to broader scientific understanding beyond E. coli O157:H7?

Research on serC in E. coli O157:H7 has potential to contribute significantly to multiple scientific domains beyond this specific pathogen:

Fundamental biochemistry and metabolism:
Understanding the structural and functional adaptations of serC could reveal general principles about how metabolic enzymes evolve to support different ecological niches while maintaining core catalytic functions. This contributes to our broader understanding of enzyme evolution and metabolic plasticity in bacteria.

Pathogen evolution and adaptation:
Studying how a core metabolic enzyme like serC functions within the context of a pathogen that has acquired numerous virulence factors through horizontal gene transfer provides insights into how pathogens integrate new genetic material with existing metabolic networks. This has relevance for understanding the evolution of other emerging pathogens.

Microbial ecology:
Insights into how serC supports E. coli O157:H7 colonization of its primary bovine reservoir contributes to our understanding of host-microbe interactions and factors that determine host specificity and adaptation. This knowledge extends to other host-associated microbes, both commensal and pathogenic.

Antimicrobial development strategies:
Approaches developed for targeting serC in E. coli O157:H7 could inform broader antimicrobial development paradigms, particularly those focused on metabolism-based interventions rather than traditional targets. This could help address the growing challenge of antimicrobial resistance.

Systems biology approaches:
Methodologies developed to study the integration of serC within broader metabolic and virulence networks can serve as models for systems-level analysis of other pathogens, advancing our ability to understand complex cellular networks.

One Health applications:
Research connecting serC function to colonization in cattle contributes to the One Health framework by highlighting the interconnections between animal reservoirs, human infection, and environmental factors in pathogen persistence and transmission.